Homebiotech

biotech

1...495051...100Page 50 of 100
Stay Connected
- Advertisement -spot_img
Latest Articles
biotech

‘Positive trends’ from phase 2 amyotrophic lateral sclerosis trial

Jim Cornall - 0
Axoltis Pharma has announced topline results of SEALS, its phase 2 clinical trial evaluating the effect of NX210c in patients with amyotrophic lateral sclerosis...

Successful results from trial of first-in-class Parkinson’s disease peptide

biotech Jim Cornall - 0

Researchers uncover how neurons deliver RNA where it is needed

biotech Jim Cornall - 0

Revvity to acquire Human Cell Design

biotech Jim Cornall - 0

Engineered immune cells trial to fight colorectal cancer approved

biotech Jim Cornall - 0
Load more